drugset / Trial / NCT01787240

Neurobiological Bases of Placebo Response in Major Depressive Disorder

NCT01787240

Phase 4 Terminated 20 enrolled Massachusetts General Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

We are doing this research study to find out if people who get better while taking a specific kind of antidepressant medication (a selective serotonin reuptake inhibitor, or SSRI) and people who get better while taking placebo (an inactive substance) have similar chemicals in their brains. Some participants may complete a procedure called Acute Tryptophan Depletion (ATD), which is a way to study the role of serotonin in depression. Some participants may also undergo a magnetic resonance-positron emission tomography (MR-PET) scan.

Timeline

Start
2012-11
Primary completion
2016-08
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 10 mg